Accidental intralenticular injection of dexametasone intravitreal implant during the treatment of refractory diabetic macular oedema
DOI:
https://doi.org/10.31288/oftalmolzh/2018/2/6769Keywords:
diabetic retinopathy, diabetic macular oedema, dexamethasone intravitreal implant, complication, intralenticular Ozurdex implantationAbstract
This article deals with the clinical case of accidental intralenticular injection of dexamethasone implant during the treatment of refractory diabetic macula oedema. The paper is based on a comprehensive research of similar clinical cases regarding this complication. The therapy algorithm chosen by the authors is early-surgery approach with cataract phacoemulsification and relocation of Ozurdex to the vitreous body, which showed positive clinical effect.
References
Prokofyeva E. Epidemiology of major eye diseases leading to blindness in Europe: a literature review / E. Prokofyeva, E. Zrenner // Ophthalmic Res. - 2012. - Vol. 47, № 4. - P. 171-88. https://doi.org/10.1159/000329603
Diabetic Retinopathy Clinical Research Network.A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Focal/Grid Photocoagulation for Diabetic Macular Edema // Ophthalmology. - 2008. - Vol. 115, № 9. - p. 1447-9.https://doi.org/10.1016/j.ophtha.2008.06.015
Cunningham E.T. A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema / E.T.Cunningham , A.P. Adamis , M. Altaweel, L.P. Aiello, N.M. Bressler, D.J. D'Amico, M. Goldbaum, D.R. Guyer, B. Katz, M. Patel, S.D Schwartz // Ophthalmology. - 2005. - Vol. 112, №10. - P. 1747-57.https://doi.org/10.1016/j.ophtha.2005.06.007
http://www.ozurdex.com/DME/About-DME
Coca-Robinot J. Accidental injections of dexamethasone intravitreal implant (Ozurdex) into the crystalline lens / J. Coca-Robinot, B. Casco-Silva, F. Armadá-Maresca, J. García-Martínez // Eur J Ophthalmol - 2014. - Vol. 24. - P. 633-6.https://doi.org/10.5301/ejo.5000439
Berarducci A. Inadvertent dexamethasone implant injection into the lens body management / A. Berarducci, I.S. Sian, R. Ling // Eur J Ophthalmol. - 2014. - Vol.24, №4. - P. 620-2.https://doi.org/10.5301/ejo.5000436
Baskan B. Ozurdex completely located inside a crystallized lens - Results of 14 months / B. Baskan, A. Cıcek, A. Gulhan, M. Gundogan, S. Goktas // American Journal of Ophthalmology. - 2016. - Vol. 4. - P. 38-40 https://doi.org/10.1016/j.ajoc.2016.08.001
Poornachandra B. Immortal Ozurdex: A 10-month follow-up of an intralenticularimplant / B. Poornachandra, V. Kumar, C. Jayadev, S.H. Dorelli, N.K. Yadav, R. Shetty // Indian J Ophthalmol. - 2017. - Vol. 65, №3. - P. 255-257. https://doi.org/10.4103/ijo.IJO_634_16
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 M. I. Kovtun, V. V. Klymenko, V. V. Sardaryan, N. M. Kovtun
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) that allows users to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author as long as they cite the source.
COPYRIGHT NOTICE
Authors who publish in this journal agree to the following terms:
- Authors hold copyright immediately after publication of their works and retain publishing rights without any restrictions.
- The copyright commencement date complies the publication date of the issue, where the article is included in.
DEPOSIT POLICY
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) during the editorial process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work with an acknowledgement of its initial publication in this journal.
- Post-print (post-refereeing manuscript version) and publisher's PDF-version self-archiving is allowed.
- Archiving the pre-print (pre-refereeing manuscript version) not allowed.
